The largest database of trusted experimental protocols
Sourced in United States, Switzerland

The NP0009 is a laboratory equipment product manufactured by Thermo Fisher Scientific. It is designed to perform a core function within the laboratory setting. No further details about the intended use or specific capabilities of the NP0009 can be provided in an unbiased and factual manner.

Automatically generated - may contain errors

25 protocols using np0009

1

Macrophage Activation Signaling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thioglycollate media (Remel, #R07178) was injected i.p. into male WT and Clec2d−/− mice for 3-5 days to elicit PECs. PECs were collected by lavage of the peritoneum with 8 ml/mouse RPMI-2%FBS, washed once with HCM, and then allowed to attach to tissue culture dishes for 30 min at 37°C. After washing off non-adherent cells, the dishes were incubated with 5 mM EDTA/PBS for 15 min to loosen the adherent macrophages. The cells were then pipetted off the dish with complete RPMI. The purity of macrophages (CD11b+, F4/80+) was greater than 95% (data not shown). The macrophages were added to 12-well plates at 2x106/well and incubated for 4h before stimulating them without or with 30 μg/ml purified histones or 40 μg/ml Zymosan for 30 min. The cells were then washed with PBS and lysed with 120 μl of RIPA buffer (Boston Bioproducts, #BP-115) containing protease inhibitors (Roche, #11697498001) and phosphatase inhibitors (Sigma, #P5726), followed by mixing with 4X LDS sample buffer (Invitrogen, #NP0008) with reducing agent (Invitrogen, #NP0009) and heating at 95°C for 10 min. Western blot was carried out to detect phospho-MAPKs (p38, ERK, JNK), phospho-Syk, and phospho-NFκB (p65), as well as total MAPKs and Syk.
+ Open protocol
+ Expand
2

RhoA Activity Assay in Cultured Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifteen Million cells were plated on regular plastic, collagen-coated or laminin-coated plates and incubated for 3 h at 37°. Cells were washed with PBS and lysed with the lysis buffer included in the RhoA activity assay kit (Cytoskeleton, BK036). Lysates were incubated with 30 µG RhoThekin beads for 1 h at 4° while rotating. Samples were washed once with wash buffer and 20 µL of 2× sample buffer (Invitrogen, NP0007 and NP0009) was added. Samples were incubated at 95° for 5 min, run on NuPAGE™ 4–12% Bis-Tris Protein Gels (Thermo Fisher, NP0321), and transferred overnight on 0.2 µM nitrocellulose membranes (Bio-rad, 1620112) in transfer buffer (25 mM Tris, 2 M glycine, 20% methanol in demineralized water). Membranes were blocked in 5% nonfat dry milk in TBS-T (pH 7.6, 20 mM Tris, 137 mM NaCl, 0.005% Tween-20 in demineralized water). Mouse anti RhoA antibody (1:500, included in kit) was incubated overnight in 0.5% nonfat dry milk in TBS-T. Membranes were washed three times in TBS-T and incubated with the secondary antibody rabbit anti-mouse HRP (1:2000; Dako, P0260) in 5% nonfat dry milk in TBS-T. Stained membranes were washed three times for 10–20 min in TBS-T and subsequently developed using ECL (Pierce, 32209). The signal intensities were measured by densitometry in ImageJ and normalized to actin loading controls.
+ Open protocol
+ Expand
3

Immunoblotting Analysis of Viral Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The virus-infected MDCK or VeroE6/TMPRSS2 cells in 6-well plates were washed with PBS and lysed in 500 μl of 1× TNT buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10% glycerol). Lysates were centrifuged at 20,630 × g for 10 min at 4 °C. The supernatant was mixed with 4× lithium dodecyl sulfate (LDS) sample buffer (Invitrogen, NP0007) and 10× sample reducing agent (Invitrogen, NP0009). Samples were boiled for 5 min and fractionated by NuPAGE 10% Bis-Tris Protein Gels (Invitrogen, NP0316BOX) and electroblotted onto polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories, 170-4156). The membranes were incubated with mouse anti-influenza A virus NS1 (Santa Cruz, sc-130568; 1:1000), mouse anti-influenza A virus M2 (Santa Cruz, sc-32238; 1:1000), mouse anti-α tubulin (Santa Cruz, sc-32293; 1:2000), or rabbit anti-SARS-CoV-2 nucleocapsid (Cell Signaling, 33336; 1:1000) antibody, followed by incubation with horseradish peroxidase-conjugated anti-mouse IgG (Jackson Immuno Research Laboratories, 115-035-003; 1:10,000) or anti-rabbit IgG (Invitrogen, G-21234; 1:10,000). The PVDF membranes were then treated with Chemi-Lumi One Super (Nacalai Tesque, 02230-30) to elicit chemiluminescent signals, which were detected and visualized using an LAS-4000 Mini apparatus (GE Healthcare).
+ Open protocol
+ Expand
4

Immunoprecipitation of RISC Complex Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in SBB buffer (1% Triton X-100, 150mM NaCl, 50mM Tris-Cl at pH 7.5, 1mM EDTA) supplemented with protease inhibitors (Sigma, P8340) and phosphatase inhibitor (Sigma, P5726). Cell lysates were incubated at 4°C for 30 min and centrifuged at 12,000 g for 10 min at 4°C. Lysates were incubated with anti-Drosha, anti-Ago2, anti-Dgcr8, and anti-IgG (negative control) nutating overnight at 4°C followed by the addition of Dynabeads™ Protein A/G (Invitrogen, 10002D/10004D) and rocking for 4 hr at 4°C. The magnetic beads were precipitated and rinsed with SBB buffer for 5 min at 4°C for three times, followed by adding sample buffer (Invitrogen, NP0007) with reducing agent (Invitrogen, NP0009) and heated at 95°C for 3 min.
+ Open protocol
+ Expand
5

Overexpression and Immunoprecipitation of Drosha

Check if the same lab product or an alternative is used in the 5 most similar protocols
pcDNA4-hDrosha, pCI HA NEDD4 or Ubiquitin_Myc_His plasmids were transfected into 293T cells at 30% confluence with lipofectamine 2000 (Invitrogen, 11668030) following the manufacturer’s instructions. 2μg/ml doxycycline was added into medium to induce Drosha overexpression. 48 hours after transfection, cells of one 10 cm dish were lysed in 100 μl SBB buffer +1% SDS (1% Triton X-100, 150mM NaCl, 50mM Tris-Cl at pH 7.5, 1mM EDTA, 1% SDS) supplemented with protease inhibitors (cOmplete, Roche-11836170001) and PhosStop (Roche-04906845001), with rocking at 4°C for 30 min. Samples were then diluted with 900 μl SBB buffer, sonicated, rocked at 4°C for 30–60 min and centrifuged at 15000 g for 20 min. Supernatants were incubated with anti-Flag M2 Magnetic Beads (Sigma, M8823) and rocked overnight at 4°C. M2 beads were washed in SBB buffer for 5 min at 4°C for three times and boiled in sample buffer (Invitrogen, NP0007) with reducing agent (Invitrogen, NP0009).
+ Open protocol
+ Expand
6

Overexpression and Immunoprecipitation of Drosha

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T cells were transfected with pcDNA4-hDrosha and pCI HA NEDD4 or pCI vector. 2μg/ml doxycycline was added into medium to induce Drosha overexpression. 48 hr after transfection, cells were lysed in SBB buffer (1% Triton X-100, 150mM NaCl, 50mM Tris-Cl at pH 7.5, 1mM EDTA) supplemented with protease inhibitors (cOmplete, Roche-11836170001) and PhosStop (Roche-04906845001). Lysates were incubated at 4°C for 30 min and centrifuged at 12,000 g for 10 min at 4°C. Lysates were incubated with anti-Flag M2 Magnetic Beads (sigma, M8823) and rocked overnight at 4°C. M2 beads were washed in SBB buffer for 5 min at 4°C for three times, and boiled in sample buffer (Invitrogen, NP0007) with reducing agent (Invitrogen, NP0009).
+ Open protocol
+ Expand
7

Drosha Overexpression and Protein Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T cells were transfected with pcDNA4-hDrosha and pCI HA NEDD4 or pCI empty vector. 2μg/ml doxycycline was added into medium to induce Drosha overexpression. 48 hours after transfection, cells were lysed in SBB buffer (1% Triton X-100, 150mM NaCl, 50mM Tris-Cl at pH 7.5, 1mM EDTA) supplemented with protease inhibitors (cOmplete, Roche-11836170001) and PhosStop (Roche-04906845001). Lysates were incubated at 4˙C for 30 min, followed by centrifugation at 12,000 g for 10 min at 4˙C. 1/10 of the lysate was saved as input sample for immunoblot. The lysate was incubated with anti-Flag M2 Magnetic Beads (sigma, M8823) and rocked overnight at 4˙C. M2 beads were then washed in SBB buffer for 5 min at 4˙C for three times, and boiled in sample buffer (Invitrogen, NP0007) with reducing agent (Invitrogen, NP0009). The elute and input are subjected to immunoblot analysis.
+ Open protocol
+ Expand
8

In vitro Cleavage Assay for Neurodegenerative Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vitro cleavage assays, 1 µg of recombinant full-length human α-syn (Abcam #ab51189), TDP-43 (R&D #AP-190) or 4N2R tau (rPeptide #T-1001–1) was incubated with or without 1 µM of each protease. Proteases requiring pre-activation were performed, as mentioned in Table S2. The following buffers were used as indicated: 100 mM sodium citrate pH 3.4, 50 mM sodium acetate pH 4.5 or 5.5 or 100 mM phosphate buffer saline (PBS) pH 7.4. Also, 1 mM EDTA and 2 mM DTT were used and each reaction was performed over 1 h at 37ºC. The assay was performed in a total volume of 19.5 µl. Protease activity was stopped by adding 7.5 µl of NuPAGE 4X LDS (Fisher Scientific #NP0007) and 3 µl of 10X reducing agent (i.e., 50 µM) (Fisher #NP0009). Samples were then immediately denatured for 10 min at 80ºC. All samples were run on precast NOVEX 4–12% Bis–Tris gels (Fisher #NP0321PK2) using MES buffer (Fisher #NP0002). The gel was then either fixed in 40% ethanol and 10% acetic acid for silver stain or transferred onto nitrocellulose membranes for Western blotting. Silver staining was performed according to the manufacturer’s instructions (Thermo Fisher #LC6070).
+ Open protocol
+ Expand
9

Progranulin Cleavage by Recombinant AEP

Check if the same lab product or an alternative is used in the 5 most similar protocols
400 ng of recombinant human progranulin (R&D #CF-2420) was incubated at 37 °C for 60 min with recombinant human AEP (R&D #2199-CY) at pH 4.5. The cleavage was stopped by adding 7.5 μl of NuPAGE 4X LDS (Fisher #NP0007), 3 μl of 10X reducing agent (Fisher #NP0009) and denatured for 10 min at 70 °C. The samples were run on precast NOVEX 4–12% Bis-Tris gels (Fisher #NP0321PK2) using MES buffer (Fisher #NP0002). The gel was fixed, and silver stained as described above. Protein bands were excised and digested in-gel with Endoproteinase Asp-N (Sigma #11054589001) as described previously [25 (link), 26 (link)]. The extracted digests were vacuum-evaporated, resuspended in 20 μl of 0.1% formic acid, and desalted using C18 ZipTips (Millipore #ZTC18M096).
+ Open protocol
+ Expand
10

Cdkl5 Protein Interactome Mapping

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cortex of three mice (P65) was removed and immediately lysed in lysis buffer (Tris-HCl 7.5 20mM, NaCl 150mM, EDTA 1mM, EGTA 1mM, Triton X-100 0.1%, PIC Sigma P8340-1x, 1mM DTT, PhosSTOP Sigma P0044-1x) on ice (glass pestle Thermo-Fisher FB56679) and centrifuged (14000g 15m). The protein concentration was determined by the Bradford method. For each sample, 1mg of protein was treated for 30m with 500U Benzonase (E1014 Sigma) at 37°C, then exposed (overnight wheel, 4°C) to 1μg of Cdkl5-Ab (Sigma HPA002847) or 1μg Rabbit IgG (Jackson 011000003 lot95014). Magnetic beads (40μl 50% Dynabeads Protein G 10003D, Life Technologies) were subsequently added to the samples, and the mixture was further incubated on the wheel for 2hrs at 4°C. The beads were washed three times (3x20m washes with lysis buffer, wheel 4°C) and proteins were eluted by boiling for 10 min in NuPage Sample Reducing Agent - DTT (30μl, Thermo-Fisher NP0009; 80°C) and loaded on a 8% SDS-PAGE or analyzed by Mass Spectrometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!